openPR Logo
Press release

Global Atopic Dermatitis Market Qualitative and Quantitative Research Report with Key Competitors Dow, Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG, Bristol-Myers Squibb Company, Bayer AG

08-21-2019 10:23 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Atopic Dermatitis  Market

Atopic Dermatitis Market

The Global Atopic Dermatitis Market research report is a comprehensive research study which is set up with the utilization of most recent qualitative and quantitative research techniques. Research experts and examiners led telephonic meetings with industry pioneers and other significant sources to gather most accurate and unbiased market news. Moreover, readers get quantitative and subjective data and information for this report from both the interest and supply sides of the worldwide Atopic Dermatitis Market. The report offers an insightful and complete investigation of the Atopic Dermatitis Market, considering market rivalry, division, drivers, restrictions, challenges, patterns, openings, local development, and other basic aspects.

Get Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-atopic-dermatitis-market

Global Atopic Dermatitis Market in the forecast period of 2019-2026. Growing number of atopic dermatitis population and robust product pipeline are the key drivers for market growth. Few of the major competitors currently working in the atopic dermatitis market are Velite Pharmaceuticals, Galderma SA, Pfizer Inc, Fujisawa Healthcare, Inc., Dow, Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG, Bristol-Myers Squibb Company, Bayer AG, Meda Pharmaceuticals Inc., Connetics Corporation, ALLERGAN, and Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Encore Dermatology, Inc., AbbVie Inc. and few among others.

The Atopic Dermatitis Market report incorporates incredible examination that enables readers to distinguish key development pockets of the worldwide Atopic Dermatitis Market. The report offers various sorts of investigation, which incorporate PESTLE examination, SWOT analysis, subjective and quantitative examination, and Porter's Five Forces examination. It extensively assesses the Pharmaceutical industry with alternate points of view to give a definite, enlightening, and exact investigation of provincial development, competition, market division, and other significant perspectives. Besides, it offers an exact record of key achievements and improvements coming to fruition in the worldwide Atopic Dermatitis Market. It mulls over both the worldwide and local advancement of the Atopic Dermatitis Market to give a total examination.

Key Developments in the Market:

• In March 2017, Regeneron Pharmaceuticals, Inc. in a collaboration with Sanofi received the US FDA approval for Dupixent (dupilumab) injection for the treatment of moderate to severe atopic dermatitis (AD) in adult patient

• In December 2016, Pfizer Inc. received the US FDA approval for Eucrisatm (crisaborole), a phosphodieterase-4 (PDE-4) inhibitor for the treatment of mild to moderate atopic dermatitis (AD) in padiatric patient as well as adult patient

Get Instant 10% discount on this report mail us at: Corporatesales@databridgemarketresearch.com

Atopic dermatitis can be defined as a chronic inflammatory skin condition that affects patients of all age group and is a result of a complex interplay of multiple factors including environmental, immunological, genetic, and pharmacologic factors.

According to the article published in National Center for Biotechnology Information 2018, It was estimated that totoal population of atopic dermatitis in the United States over 4.9% , in Canada 4.4% and 3.5% in Europe. The prevalent was higher in female as comapared to male. Increasing number of atopic dermatitis cases worldwide and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.

Market Drivers

• Strong product pipeline for atopic dermatitis
• Availability of novel drug therapies and generic alternatives
• Increase in awareness of atopic dermatitis
• Growing cases of atopic dermatitis worldwide

Market Restraints

• Upcoming patent expiry of products of many companies
• Allergic reactions of off-label therapies
• Effective treatment is either unavailable or unaffordable

Market Segmentation:

By Mechanism of Action Type

• Antihistamines
• Topical corticosteroids
• Emollients
• Phosphodieterase-4 (PDE-4) inhibitor
• Topical antiseptic
• Others

By Mode of Administration

• Injectable
• Topical
• Oral

By Drug Type

• Triamcinolone
• Clobetasol
• Tacrolimus topical
• Betamethasone
• Pimecrolimus
• Fluocinonide
• Hydrocortisone
• Prednisone
• Crisaborole
• Fluticasone
• Methylprednisolone
• Others

By End- User

• Hospitals
• Research Centers
• Clinics
• Home Care

By Distribution Channel

• Mail Order Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores
• Retail Pharmacies
• Dermatology Clinics

By Geography

• North America

• South America

• Europe

• Asia-Pacific

• Middle East & Africa

For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-atopic-dermatitis-market

Competitive Analysis: Global Atopic Dermatitis Market

Global atopic dermatitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of atopic dermatitis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

• Current and future of global atopic dermatitis market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Contents:

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Download Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-atopic-dermatitis-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Atopic Dermatitis Market Qualitative and Quantitative Research Report with Key Competitors Dow, Regeneron Pharmaceuticals, Inc, LEO Pharma A/S, Sanofi, Novartis AG, Bristol-Myers Squibb Company, Bayer AG here

News-ID: 1824413 • Views: 413

More Releases from Data Bridge Market Research

Seafood Processing Equipment Market Status Analysis and Forecast 2026 By ARCOS L …
Global Seafood Processing Equipment Market is expected to rise from its initial estimated value of USD 2.03 billion in 2018 to an estimated value of USD 2.68 billion by 2026, registering a CAGR of 3.51% in the forecast period of 2019-2026. Increase in the demand for the healthy food is the major factor for the growth of this market. seafood processing equipment market report comprises of historic data along with future
Flow Chemistry Market Forecast Until 2026 By CEM Corporation, Syrris Ltd, Vapour …
A DBMR team uses simple language and easy to understand statistical images to provide thorough information and in-depth data on the chemical industry and flow chemistry market. The company profiles of all the key players and brands that are dominating the market have been taken into consideration here. The report also shares gross margin, market share, attractiveness index, and value and volume growth of all of the segments studied by
Fintech Block Chain Market Forecasts 2019 to 2025: By AWS, IBM, Microsoft, Rippl …
Global Fintech Block Chain Market accounted for USD 232.0 billion in 2017 and is projected to grow at a CAGR of 76.2% the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The fintech block chain report explains market analysis based on regional, local as well as global level.
Well Intervention Market 2019:Dynamics and Development By Schlumberger Limited, …
Global Well Intervention Market is expected to rise from its initial estimated value of USD 8.75 billion in 2018 to an estimated value of USD 13.37 billion by 2026, registering a CAGR of 5.45% in the forecast period of 2019-2026. Increasing demand for energy is the major factor driving the growth of this market. The report covers several topics including market trend analysis, market drivers, market restraints, opportunities, threats, application analysis,

All 5 Releases


More Releases for Atopic

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018 - ResearchByMarkets …
"Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018", provides an overview of the Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline landscape. Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from
Atopic Dermatitis Treatment Market | SWOT Analysis of Major Market Segments
Atopic dermatitis (AD) is a type of skin disorder in which the skin becomes dry, itchy and inflamed. Scratching of the skin leads to redness, swelling, scaling, cracking, weeping and crusting. Though, this condition is most common in infants and children, also affects adult population. AD is considered as idiopathic, a disease without a known cause, and is likely to be caused by both genetic as well as environmental factors.
Atopic Dermatitis Industry to show steady growth, H2 2017
Overview Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from scratching. Risk factors include family history of eczema, allergies, hay fever or asthma and gender.  Click here for sample report @
Recent Research: Atopic Dermatitis Treatment Market Analysis to 2019
Atopic dermatitis (AD) is a type of skin disorder in which the skin becomes dry, itchy and inflamed. Scratching of the skin leads to redness, swelling, scaling, cracking, weeping and crusting. Though, this condition is most common in infants and children, also affects adult population. AD is considered as idiopathic, a disease without a known cause, and is likely to be caused by both genetic as well as environmental factors.
Atopic Dermatitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atopic Dermatitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Pipeline Review, H2 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape. Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored
Global Atopic Dermatitis Treatment Market Research Report 2017
Report Hive Market Research Released a New Research Report of 103 pages on Title " Global Atopic Dermatitis Treatment Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Atopic Dermatitis Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report